This announcement is a separate document:
四川百利天恒药业股份有限公司2023年度内部控制评价报告
Sichuan Baili Tianheng Pharmaceutical Co., Ltd. 2023 Internal Control Evaluation Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.